Publicaciones en las que colabora con REBECA LORCA GUTIERREZ (50)

2024

  1. Concealed Inherited Cardiomyopathies Detected in Cardio-Oncology Screening

    Journal of Clinical Medicine, Vol. 13, Núm. 1

  2. Natural History of Dilated Cardiomyopathy Due to c.77T>C (p.Val26Ala) in Emerin Protein

    Journal of Clinical Medicine, Vol. 13, Núm. 3

  3. “Inherited cardiovascular disease mindset” can identify concealed inherited conditions at cardio-oncology evaluation: An opportunistic screening.

    International Journal of Cardiology, Vol. 401

2023

  1. Chromosome Y Haplogroup R Was Associated with the Risk of Premature Myocardial Infarction with ST-Elevation: Data from the CholeSTEMI Registry

    Journal of Clinical Medicine, Vol. 12, Núm. 14

  2. Clinical Evaluation of Patients with Genetically Confirmed Familial Hypercholesterolemia

    Journal of Clinical Medicine, Vol. 12, Núm. 3

  3. Mitochondrial Heteroplasmy as a Marker for Premature Coronary Artery Disease: Analysis of the Poly-C Tract of the Control Region Sequence

    Journal of Clinical Medicine, Vol. 12, Núm. 6

  4. Opportunistic Genetic Screening for Familial Hypercholesterolemia in Heart Transplant Patients

    Journal of Clinical Medicine, Vol. 12, Núm. 3

  5. STEMI in women. Life expectancy recovery after primary percutaneous coronary intervention

    Revista Espanola de Cardiologia, Vol. 76, Núm. 12, pp. 1003-1012

2022

  1. Association of the Genetic Variation in the Long Non‐Coding RNA FENDRR with the Risk of Developing Hypertrophic Cardiomyopathy

    Life, Vol. 12, Núm. 6

  2. Different Phenotypes in Monozygotic Twins, Carriers of the Same Pathogenic Variant for Hypertrophic Cardiomyopathy

    Life, Vol. 12, Núm. 9

  3. KCNH2 p.Gly262AlafsTer98: A New Threatening Variant Associated with Long QT Syndrome in a Spanish Cohort

    Life, Vol. 12, Núm. 4

  4. Natural History of MYH7-Related Dilated Cardiomyopathy

    Journal of the American College of Cardiology, Vol. 80, Núm. 15, pp. 1447-1461

  5. Permanent Pacemaker Reduction Using Cusp-Overlapping Projection in TAVR: A Propensity Score Analysis

    JACC: Cardiovascular Interventions, Vol. 15, Núm. 2, pp. 150-161

2021

  1. Compound heterozygosity for PTPN11 variants in a subject with Noonan syndrome provides insights into the mechanism of SHP2-related disorders

    Clinical Genetics, Vol. 99, Núm. 3, pp. 457-461

  2. Evaluation of cardiovascular events in patients with hepatocellular carcinoma treated with sorafenib in the clinical practice. The CARDIO-SOR study

    Liver International, Vol. 41, Núm. 9, pp. 2200-2211

  3. Frailty assessment in a cohort of elderly patients with severe symptomatic aortic stenosis: Insights from the frailty evaluation in severe aortic stenosis (fresas) registry

    Journal of Clinical Medicine, Vol. 10, Núm. 11

  4. Premature stemi in men and women: Current clinical features and improvements in management and prognosis

    Journal of Clinical Medicine, Vol. 10, Núm. 6

  5. STEMI, primary percutaneous coronary intervention and recovering of life expectancy: insights from the SurviSTEMI study

    Revista Espanola de Cardiologia, Vol. 74, Núm. 10, pp. 829-837

  6. The APOB polymorphism rs1801701 A/G (p.R3638Q) is an independent risk factor for early-onset coronary artery disease: Data from a Spanish cohort

    Nutrition, Metabolism and Cardiovascular Diseases, Vol. 31, Núm. 5, pp. 1564-1568

2020

  1. Angiotensin-converting enzymes (ACE, ACE2) gene variants and COVID-19 outcome

    Gene, Vol. 762